Dr Joakim Crona provides an overview of practice changing clinical trials within the field of neuroendocrine tumours and neuroendocrine carcinomas
Endocrinology Oncology Rare diseases
Practice changing clinical trials in NET
Publication Date
Nov 2019
Joakim Crona is a resident in clinical oncology and associate professor in molecular oncology at Uppsala Academic Hospital, Sweden. He’s had a particular interest for neuroendocrine tumors since more than eight years. This included successfully defending his thesis covering genetics of neuroendocrine tumors, as well as working as a physician at the clinic of endocrine oncology. Joakim has just returned from a short term fellowship at the Pheochromocytoma/Paraganglioma Program, US National Institutes of Health. He plans a future career in the field of endocrine oncology that will unite clinical science with molecular biology, aiming at improving treatment of patients with these rare diseases.
Dr Joakim Crona has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Novartis.
DOWNLOAD SLIDES 
Programme summary
Duration 5 MIN- Downloadable resources Yes
-
DOWNLOAD SLIDES
- Language(s)
Duration 
Language(s) 
Share this programme
Brought to you by
NET CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from Ipsen and from Eisai Europe Limited.
Meet the expertsOther programmes of interest
Video
Oncology
Celebrating the 10th anniversary of GI CONNECT
10 years of independent medical education in GI oncology
Experts
Assoc. Prof. Gerald Prager, Assoc. Prof. Joleen Hubbard, Dr Thomas Winder, Prof. Andrea Sartore-Bianchi, Dr Dominik Modest-
2 MIN
-
Apr 2024
2 MIN
Apr 2024 
Tweetorial
Oncology
Tweetorial video: Treating ER+/HER2-low metastatic breast cancer, 2L and beyond
Journey through a patient case from testing and diagnosis to treatment and AE management
Experts
Dr Aditya BardiaEndorsed by
-
11 MIN
-
Apr 2024
Podcast
Oncology
Perseverance in molecular testing in NSCLC pays off
Looking beyond the obvious mutations in non-small-cell lung cancer
Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski-
Downloadable
Resources -
26 MIN
-
Mar 2024
Downloadable 
Conference update
Oncology
ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Experts
Prof. Valentina Guarneri, Prof. Matteo Lambertini, Prof. Federico Rojo-
Downloadable
Resources -
6 MIN
-
Mar 2024
Podcast
Oncology
mCRC: Optimising patient outcomes with late-line treatment
Maximising outcomes for patients with advanced CRC
Experts
Assoc. Prof. Gerald Prager, Dr Victor Hugo Fonseca de JesusEndorsed by
-
Downloadable
Resources -
23 MIN
-
Mar 2024
Interactive patient case
Oncology
TRK fusion-positive lung cancer: Diagnosis and treatment
Make decisions for your patient at two key stages in their journey
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
Mar 2024
